Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer|Unspecified Adult Solid Tumor, Protocol Specific
Interventions: BIOLOGICAL: adenovirus-p53 transduced dendritic cell (DC) vaccine|DRUG: 1-methyl-d-tryptophan|OTHER: Laboratory biomarker analysis
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: National Cancer Institute (NCI)